Steven Cohen Xencor Inc Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Xencor Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,558 shares of XNCR stock, worth $14,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,558

Previous 1,023,673 99.85%

Holding current value

$14,411

Previous $10.9 Million 99.89%

% of portfolio

0.0%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.52 - $11.26 $7.69 Million - $11.5 Million	-1,022,115 Reduced 99.85%	1,558 $12,000
Q1 2025 May 15, 2025	SELL	$10.64 - $24.13 $12.3 Million - $27.8 Million	-1,153,408 Reduced 52.98%	1,023,673 $10.9 Million
Q4 2024 Feb 14, 2025	SELL	$19.43 - $26.84 $18.3 Million - $25.3 Million	-943,148 Reduced 30.23%	2,177,081 $50 Million
Q3 2024 Nov 14, 2024	BUY	$15.7 - $21.65 $29.2 Million - $40.2 Million	1,858,440 Added 147.29%	3,120,229 $62.7 Million
Q2 2024 Aug 14, 2024	BUY	$18.21 - $24.5 $7.95 Million - $10.7 Million	436,389 Added 52.87%	1,261,789 $23.9 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $15.4 Million - $21.9 Million	825,400 New	825,400 $18.3 Million
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $42,569 - $53,826	2,120 Added 609.2%	2,468 $49,000
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $8,619 - $10,405	348 New	348 $8,000
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $72,660 - $103,460	-2,800 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $69,412 - $86,408	2,800 New	2,800 $72,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $6.37 Million - $9.37 Million	-322,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $9.19 Million - $14.3 Million	-344,617 Reduced 51.63%	322,900 $8.62 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $15.7 Million - $20.3 Million	467,117 Added 233.09%	667,517 $26.8 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $6.14 Million - $7.15 Million	200,400 New	200,400 $6.55 Million
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $4.72 Million - $6.14 Million	-137,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $995,764 - $1.31 Million	24,400 Added 21.59%	137,400 $5.92 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $2.83 Million - $3.69 Million	77,392 Added 217.34%	113,000 $4.93 Million
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $1.07 Million - $1.53 Million	35,608 New	35,608 $1.38 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $4.82 Million - $6.1 Million	-147,290 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$33.73 - $46.27 $4.97 Million - $6.82 Million	147,290 New	147,290 $4.97 Million
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $10.1 Million - $13.9 Million	-340,445 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$27.85 - $38.09 $5.16 Million - $7.06 Million	185,445 Added 119.64%	340,445 $10.6 Million
Q4 2018 Feb 14, 2019	BUY	$32.39 - $42.05 $3.81 Million - $4.94 Million	117,500 Added 313.33%	155,000 $5.61 Million
Q3 2018 Nov 14, 2018	BUY	$35.69 - $47.65 $1.34 Million - $1.79 Million	37,500 New	37,500 $1.46 Million
Q4 2017 Feb 14, 2018	SELL	$19.29 - $24.83 $964,500 - $1.24 Million	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $980,500 - $1.17 Million	50,000	50,000 $1.15 Million

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

81.9M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $552M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account